The Drug Discovery Innovators & Investors (DDII) London, UK Conference brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors for a focused day of discussion, collaboration and networking.

Taking place at etc.venues in Monument, London, UK on Wednesday 4 November 2026, the conference will examine the technologies, funding and partnerships shaping the future of UK drug discovery and development.

Registration is now open, with Early Bird rates available until 16 October.

Here are five reasons to attend:

  1. Hear directly from industry leaders
    The programme brings together senior voices from across drug discovery and development sector. Chris Molloy, CEO of the UK BioIndustry Association (BIA), will deliver the keynote, alongside speakers from GSK, the Liverpool School of Tropical Medicine, Cell and Gene Therapy Catapult, Cancer Research Horizons Ventures and leading investment firms. More speakers to be announced soon.
  2. Practical insight into the issues facing drug development
    The conference tackles the sector’s biggest challenges, from speeding up clinical trials to finding capital in a challenging funding environment. Sessions include “Get It Done: Designing Faster, More Effective UK Clinical Trials” and “Where Is the Money? Funding Early-Stage UK Drug Development in a Difficult Market”.
  3. Explore technologies you can apply to your work
    Small-group breakout workshops will let attendees go deeper into areas such as AI in drug discovery, lab automation, spatial biology, cell and gene therapy, and toxicology. Further details to be announced soon.
  4. Make the right connections before you arrive
    The dedicated conference app allows attendees to browse delegate profiles and arrange 1:1 meetings in advance. Networking sessions have been built into the agenda to help you connect with technology suppliers, buyers, investors, collaborators or clinical trial partners.
  5. Connect with a conference backed by the industry
    DDII UK is supported by Drug Discovery World (DDW) along with Cancer Research Horizons, One Nucleus, One Life Sciences, Gain Therapeutics, BiotechGate, HollandBio, CSEM, SiLA and Zyme Communications.

The result is a conference built around the people, technologies and investment shaping UK drug discovery bringing everyone together in one place.

Register now.